In the year 1985, Cameron Clokie graduated as a Doctor of Dental Surgery. This was followed by a quick succession of extensive studies in medicine which he completed in 1990. In 1992, he earned a Doctorate in the regeneration of dental implants from McGill University. He has since made a name for himself in the medical field, especially in bone reconstruction and regeneration.
He is currently the CEO of Induce Inc., a company specializing in the production of generative bio-implants. The initiative aids to reduce the need of harvesting bones from other parts of the body so as to reconstruct.
Under Dr. Cameron, Induce Inc. has been able to produce a bone morphogenetic protein which induces bones (especially in adults) to grow again in young children. Peter Russel is a living testimony of the work of BPM having fully regrown his jaw which he had lost to a tumor. Read more: Cameron Clokie Speaks to Regenerative Medicine
Cameron Clokie is also committed to teaching and giving others information regarding his field of expertise. In line with this, he has conducted a lot of lectures globally to different audiences.
During the sessions, he discusses what the future holds for regenerative medicine and development of bio-implants, Oral and Maxillofacial Surgery, and other topics surrounding medicine. He also has many publications to his name which are circulated internationally in print and on the internet.
About Cameron Clokie
Cameron Clokie worked at the University of Toronto as the Head of Oral and Maxillofacial Surgery and as a professor in the same field. He holds over 25 globally known patents that revolve around bone treatment.
He has been called to serve in several companies where he has also been the advisor. He has also put his entrepreneurial side into action having established several business alliances where he has put his knowledge into profit and non-profit generation enterprises.
Currently, Cameron Clokie has all his attention in the development and further improvement of BPM. He aims at making it better, more efficient with minimal side effects and most importantly, reducing its cost. It currently costs more than $6000, and medical covers do not cover it, which makes it only accessible to few people.